These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Preoperative assessment of gut hormones does not correlate to weight loss after Roux-en-Y gastric bypass surgery. Werling M; Fändriks L; Vincent RP; Cross GF; le Roux CW; Olbers T Surg Obes Relat Dis; 2014; 10(5):822-8. PubMed ID: 25282191 [TBL] [Abstract][Full Text] [Related]
4. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. le Roux CW; Welbourn R; Werling M; Osborne A; Kokkinos A; Laurenius A; Lönroth H; Fändriks L; Ghatei MA; Bloom SR; Olbers T Ann Surg; 2007 Nov; 246(5):780-5. PubMed ID: 17968169 [TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery. Federico A; Dallio M; Tolone S; Gravina AG; Patrone V; Romano M; Tuccillo C; Mozzillo AL; Amoroso V; Misso G; Morelli L; Docimo L; Loguercio C In Vivo; 2016; 30(3):321-30. PubMed ID: 27107092 [TBL] [Abstract][Full Text] [Related]
6. Gastric bypass surgery restores meal stimulation of the anorexigenic gut hormones glucagon-like peptide-1 and peptide YY independently of caloric restriction. Evans S; Pamuklar Z; Rosko J; Mahaney P; Jiang N; Park C; Torquati A Surg Endosc; 2012 Apr; 26(4):1086-94. PubMed ID: 22044971 [TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. Morínigo R; Moizé V; Musri M; Lacy AM; Navarro S; Marín JL; Delgado S; Casamitjana R; Vidal J J Clin Endocrinol Metab; 2006 May; 91(5):1735-40. PubMed ID: 16478824 [TBL] [Abstract][Full Text] [Related]
9. Selective release of gastrointestinal hormones induced by an orally active GPR39 agonist. Grunddal KV; Diep TA; Petersen N; Tough IR; Skov LJ; Liu L; Buijink JA; Mende F; Jin C; Jepsen SL; Sørensen LME; Achiam MP; Strandby RB; Bach A; Hartmann B; Frimurer TM; Hjorth SA; Bouvier M; Cox H; Holst B Mol Metab; 2021 Jul; 49():101207. PubMed ID: 33711555 [TBL] [Abstract][Full Text] [Related]
10. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. le Roux CW; Aylwin SJ; Batterham RL; Borg CM; Coyle F; Prasad V; Shurey S; Ghatei MA; Patel AG; Bloom SR Ann Surg; 2006 Jan; 243(1):108-14. PubMed ID: 16371744 [TBL] [Abstract][Full Text] [Related]
11. Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes Mellitus and Obesity. Maselli DB; Camilleri M Adv Exp Med Biol; 2021; 1307():171-192. PubMed ID: 32077010 [TBL] [Abstract][Full Text] [Related]
12. Orlistat inhibition of intestinal lipase acutely increases appetite and attenuates postprandial glucagon-like peptide-1-(7-36)-amide-1, cholecystokinin, and peptide YY concentrations. Ellrichmann M; Kapelle M; Ritter PR; Holst JJ; Herzig KH; Schmidt WE; Schmitz F; Meier JJ J Clin Endocrinol Metab; 2008 Oct; 93(10):3995-8. PubMed ID: 18647814 [TBL] [Abstract][Full Text] [Related]
13. Gastric bypass surgery: improving psoriasis through a GLP-1-dependent mechanism? Faurschou A; Zachariae C; Skov L; Vilsbøll T; Knop FK Med Hypotheses; 2011 Dec; 77(6):1098-101. PubMed ID: 21968278 [TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal hormones and weight loss response after Roux-en-Y gastric bypass. de Hollanda A; Jiménez A; Corcelles R; Lacy AM; Patrascioiu I; Vidal J Surg Obes Relat Dis; 2014; 10(5):814-9. PubMed ID: 24969090 [TBL] [Abstract][Full Text] [Related]
15. Ghrelin suppresses cholecystokinin (CCK), peptide YY (PYY) and glucagon-like peptide-1 (GLP-1) in the intestine, and attenuates the anorectic effects of CCK, PYY and GLP-1 in goldfish (Carassius auratus). Blanco AM; Bertucci JI; Valenciano AI; Delgado MJ; Unniappan S Horm Behav; 2017 Jul; 93():62-71. PubMed ID: 28506816 [TBL] [Abstract][Full Text] [Related]
16. Exogenous peptide YY3-36 and Exendin-4 further decrease food intake, whereas octreotide increases food intake in rats after Roux-en-Y gastric bypass. Fenske WK; Bueter M; Miras AD; Ghatei MA; Bloom SR; le Roux CW Int J Obes (Lond); 2012 Mar; 36(3):379-84. PubMed ID: 21694700 [TBL] [Abstract][Full Text] [Related]
17. The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity. Flint A; Raben A; Ersbøll AK; Holst JJ; Astrup A Int J Obes Relat Metab Disord; 2001 Jun; 25(6):781-92. PubMed ID: 11439290 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss. Holst JJ; Madsbad S; Bojsen-Møller KN; Svane MS; Jørgensen NB; Dirksen C; Martinussen C Surg Obes Relat Dis; 2018 May; 14(5):708-714. PubMed ID: 29776493 [TBL] [Abstract][Full Text] [Related]
19. Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intake. Bojsen-Møller KN; Svane MS; Martinussen C; Dirksen C; Jørgensen NB; Jensen JB; Jensen CZ; Torekov SS; Kristiansen VB; Rehfeld JF; Bork-Jensen J; Grarup N; Hansen T; Hartmann B; Holst JJ; Madsbad S Int J Obes (Lond); 2023 Nov; 47(11):1143-1151. PubMed ID: 37653071 [TBL] [Abstract][Full Text] [Related]
20. GLP-1 Analog Modulates Appetite, Taste Preference, Gut Hormones, and Regional Body Fat Stores in Adults with Obesity. Kadouh H; Chedid V; Halawi H; Burton DD; Clark MM; Khemani D; Vella A; Acosta A; Camilleri M J Clin Endocrinol Metab; 2020 May; 105(5):1552-63. PubMed ID: 31665455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]